Evidence map›Paper›PMID 23198089›Full record

ArticleScientific reports2012

Juxtanodin is an intrinsically disordered F-actin-binding protein.

Salla Ruskamo, Maryna Chukhlieb, Juha Vahokoski, Saligram Prabhakar Bhargav, Fengyi Liang, Inari Kursula, Petri Kursula

Abstract read
In one paragraph

Article in Scientific reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Generation of the configurational ensemble of an intrinsically disordered protein from unbiased molecular dynamics simulation.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Salla RuskamoDepartment of Biochemistry, University of Oulu, Oulu, Finland.
Maryna Chukhlieb
Juha Vahokoski
Saligram Prabhakar Bhargav
Fengyi Liang
Inari Kursula
Petri Kursula

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Juxtanodin, also called ermin, is an F-actin-binding protein expressed by oligodendrocytes, the myelin-forming cells of the central nervous system. While juxtanodin carries a short conserved F-actin-binding segment at its C terminus, it otherwise shares no similarity with known protein sequences. We carried out a structural characterization of recombinant juxtanodin in solution. Juxtanodin turned out to be intrinsically disordered, as evidenced by conventional and synchrotron radiation CD spectroscopy. Small-angle X-ray scattering indicated that juxtanodin is a monomeric, highly elongated, unfolded molecule. Ensemble optimization analysis of the data suggested also the presence of more compact forms of juxtanodin. The C terminus was a strict requirement for co-sedimentation of juxtanodin with microfilaments, but juxtanodin had only mild effects on actin polymerization. The disordered nature of juxtanodin may predict functions as a protein interaction hub, although F-actin is its only currently known binding partner.

Indexed as

ActinsAlgorithmsAmino Acid SequenceAnimalsCarrier ProteinsCircular DichroismMicrofilament ProteinsMicroscopy, ElectronMolecular Sequence DataMuscle, SkeletalProtein BindingProtein Structure, SecondaryRatsRecombinant ProteinsScattering, Small AngleSequence Homology, Amino AcidActinsCarrier ProteinsErmn protein, ratF-actin-binding proteinsMicrofilament ProteinsRecombinant ProteinsSolutions

Identifiers

PMID23198089
PMCPMC3509349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.